Treatment of mild to moderate seborrhoeic dermatitis with MAS064D (Sebclair®), a novel topical medical device: Results of a pilot, randomized, double-blind, controlled trial

Journal of the European Academy of Dermatology and Venereology

Volumn 22, Issue 3, 2008, Pages 290-296

  Veraldi, Stefano ^a   Menter, A ^b   Innocenti, M ^c  

^a UNIVERSITY OF MILAN   (Italy)

^b BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^c European Institute of Dermatology   (Italy)

Author keywords

Antimycotics; Corticosteroids; MAS064D; Sebclair ; Seborrhoeic dermatitis

Indexed keywords

ALLANTOIN; ALPHA TOCOPHEROL; ANTIINFLAMMATORY AGENT; BISABOLOL; DERMATOLOGICAL AGENT; DESONIDE; GLYCYRRHETINIC ACID; HEXADECANE; MAS 064D; PIROCTONE ETHANOLAMINE; SEBCLAIR; TELMESTEINE; UNCLASSIFIED DRUG; VITIS VINIFERA EXTRACT;

ADULT; ARTICLE; BURNING SENSATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREAM; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ERYTHEMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT COMPLIANCE; PATIENT SAFETY; PILOT STUDY; PRIORITY JOURNAL; PRURITUS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SEBORRHEIC DERMATITIS;

ADMINISTRATION, TOPICAL; ADULT; AGED; ALKANES; ALLANTOIN; DERMATITIS, SEBORRHEIC; DERMATOLOGIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; ETHANOLAMINES; FEMALE; HUMANS; MALE; MIDDLE AGED; OINTMENTS; PILOT PROJECTS; PYRIDONES; QUALITY OF LIFE; SESQUITERPENES; SEVERITY OF ILLNESS INDEX; THIAZOLIDINES; TREATMENT OUTCOME; VITAMIN E;

EID: 39149109290     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2007.02404.x     Document Type: Article

References (26)

1. Gupta AK, Bluhm R, Cooper EA, Summerbell RC, Batra R. Seborrheic dermatitis. Dermatol Clin 2003; 21: 401-412.
2. Hay RJ, Graham-Brown RAC. Dandruff and seborrhoeic dermatitis: Causes and management. Clin Exp Dermatol 1997; 22: 3-6.
3. Gemmer CM, DeAngelis YM, Theelen B, Boekhout T, Dawson TL Jr. Fast, noninvasive method for molecular detection and differentiation of Malassezia yeast species on human skin and application of the method to dandruff microbiology. J Clin Microbiol 2002; 40: 3350-3357.
4. Sandström Falk MH, Tengvall Linder M, Johansson C et al. The prevalence of Malassezia yeasts in patients with atopic dermatitis, seborrhoeic dermatitis and healthy controls. Acta Derm Venereol 2005; 85: 17-23.
5. Faergemann J, Bergbrant I-M, DohséM, Scott A, Westgate G. Seborrhoeic dermatitis and Pityrosporum (Malassezia) folliculitis: characterization of inflammatory cells and mediators in the skin by immunohistochemistry. Br J Dermatol 2001; 144: 549-556.
6. Neuber K, Kröger S, Gruseck E, Abeck D, Ring J. Effects of Pityrosporum ovale on proliferation, immunoglobulin (IgA, G, M) synthesis and cytokine (IL-2, IL-10, IFNγ) production of peripheral blood mononuclear cells from patients with seborrhoeic dermatitis. Arch Dermatol Res 1996; 288: 532-536.
7. Silva V, Fischman O, de Camargo ZP. Humoral immune response to Malassezia furfur in patients with pityriasis versicolor and seborrheic dermatitis. Mycopathologia 1997; 139: 79-85.
8. Parry ME, Sharpe GR. Seborrhoeic dermatitis is not caused by an altered immune response to Malassezia yeast. Br J Dermatol 1998; 139: 254-263.
9. Gupta AK, Bluhm R, Barlow JO, Fleischer AB, Feldman SR. Prescribing practices for seborrheic dermatitis vary with the physician's specialty: implications for clinical practice. J Dermatol Treat 2004; 15: 208-213.
10. Braza TJ, DiCarlo JB, Soon SL, McCall CO. Tacrolimus 0.1% ointment for seborrhoeic dermatitis: An open-label pilot study. Br J Dermatol 2003; 148: 1242-1244.
11. Crutchfield CE III. Pimecrolimus: A new treatment for seborrheic dermatitis. Cutis 2002; 70: 207-208.
12. Amagaya S, Sugishita E, Ogihara Y, Ogawa S, Okada K, Aizawa T. Comparative studies of the stereoisomers of glycyrrhetinic acid on anti-inflammatory activities. J Pharmacobiodyn 1984; 7: 923-928.
13. Bombardelli E, Curri SB, Della Loggia R et al. Anti-inflammatory activity of 18-β-glycyrrhetinic acid in Phytosome® form. Fitoterapia 1989; 60: 29-37.
14. Teelucksingh S, Mackie ADR, Burt D, McIntyre MA, Brett L, Edwards CR. Potentiation of hydrocortisone activity in skin by glycyrrhetinic acid. Lancet 1990; 335: 1060-1063.
15. Schmidt A. Malassezia furfur: A fungus belonging to the physiological skin flora and its relevance in skin disorders. Cutis 1997; 59: 21-24.
16. Schmidt A, Ruhl-Horster B. In vitro susceptibility of Malassezia furfur. Arzneimittelforschung 1996; 46: 442-444.
17. Cooper R, Morre DJ, Morre DM. Medicinal benefits of green tea: Part I. Review of noncancer health benefits. J Altern Complement Med 2005; 11: 521-528.
18. Maffei Facino R, Carini M, Aldini G, Bombardelli E, Morazzoni P, Morelli R. Free radicals scavenging action and anti-enzyme activities of procyanidines from Vitis vinifera. A mechanism for their capillary protective action. Arzneimittelforschung 1994; 44: 592-601.
19. Hopkins SJ. Telmesteine. Drugs Today 1993; 29: 129-131.
20. Singh U, Devaraj S, Jialal I. Vitamin E, oxidative stress and inflammation. Annu Rev Nutr 2005; 25: 151-174.
21. Grassi L, Moretti M, Bisetti A. Un nuovo farmaco mucoattivo con attivitàanti-proteasica: La telmesteina. Riv Ital Biol Med 1992; 12: 67-74.
22. Georgalas A. Enhanced delivery of an anti-dandruff active in a shampoo vehicle. J Cosmet Sci 2004; 55 (Suppl.): S207-S2014.
23. Piérard-Franchimont C, Piérard GE. A double-blind placebo-controlled study of ketoconazole + desonide gel combination in the treatment of facial seborrheic dermatitis. Dermatology 2002; 204: 344-347.
24. Kose O, Erbil H, Gur AR. Oral itraconazole for the treatment of seborrhoeic dermatitis: An open, noncomparative trial. JEADV 2005; 19: 172-175.
25. Baysal V, Yildirim M, Ozcanli C, Ceyhan AM. Itraconazole in the treatment of seborrheic dermatitis: A new treatment modality. Int J Dermatol 2004; 43: 63-66.
26. Food & Drug Administration Synopsis of Agents Generally Regarded as Safe. http://www.cfsan.fda.gov/~rdb/opa-gras.html.